Join StocksJar.com -Get 7 Days Free trial

Elevance Health (ELV) Stock Price & AI Analysis

NYSE
USA

$382.14

-$1.06
(-0.45%)

Subscribe to get
AI Score

  • Market Cap 88.63B
  • Volume 2.72M
  • Avg Volume 1.67M
  • Target Price $607.87
  • 52W Range 391.02 - 567.26
  • RSI (14) 28.7
  • Beta 0.83
  • PEG Ratio 1.55
  • SMA 20 -5.54
  • SMA 50 -12.47
  • SMA 200 -24.33
  • Insider Owner 0.21%
  • Insider Trans -8.02%
  • Institution Owner 90.31%
  • Institution Trans -1.55%
  • Short Interest 3.13%
  • EPS next Y 5.34

Elevance Health Company Profile

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Elevance Health | Latest news

Supplement recall update: FDA adds two more toxic products to safety alert

Supplement recall update: FDA adds two more toxic products to safety alert

Two products have been added to a safety alert by the U.S. Food and Drug Administration (FDA) on...

Newsweek - 3 days ago

Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?

Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?

Elevance Health, Inc. (NYSE:ELV) saw significant share price movement during recent months on the...

Simply Wall St - 3 days ago

Elevance Health, Inc. (ELV): A Bull Case Theory

Elevance Health, Inc. (ELV): A Bull Case Theory

We came across a bullish thesis on Elevance Health, Inc. (ELV) on Substack by Stock Analysis Compilation. In this article, we will summarize the bulls’...

Insider Monkey - 7 days ago

UnitedHealthcare and other insurers are pulling info about execs offline after a...

UnitedHealthcare and other insurers are pulling info about execs offline after a...

UnitedHealthcare (UNH) has taken down its leadership page from its website, following the fatal...

Quartz - 1 day ago

Elevance Health Stock Falls As Anthem Faces Backlash Over Anesthesia Policy,...

Elevance Health Stock Falls As Anthem Faces Backlash Over Anesthesia Policy,...

Anthem Blue Cross Blue Shield reverses a controversial policy limiting anesthesia reimbursements...

Benzinga - 1 day ago

Analysts Set Elevance Health, Inc. (NYSE:ELV) Target Price at $539.20

Analysts Set Elevance Health, Inc. (NYSE:ELV) Target Price at $539.20

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the sixteen ratings firms that are currently covering the company ...

ETF DAILY NEWS - 5 days ago

UnitedHealth Has Worst Week Since Covid Shutdown After Health Insurance Exec's...

UnitedHealth Has Worst Week Since Covid Shutdown After Health Insurance Exec's...

The fatal shooting of the chief executive of UnitedHealth Group's (UNH) insurance division on...

Investor39s Business Daily - 23 hours ago

Anthem takes back plan to limit anesthesia coverage after public backlash

Anthem takes back plan to limit anesthesia coverage after public backlash

Anthem Blue Cross Blue Shield (ELV) (BCBS) is backing off of a plan that would have placed a cap on...

Quartz - 2 days ago

Elevance Health Inc (ELV) Under Investigation for Potential Secu

Elevance Health Inc (ELV) Under Investigation for Potential Secu

On December 4, 2024, Johnson Fistel, LLP, a shareholder rights law firm, announced an investigation into Elevance Health Inc (ELV, Financial) to determine whether the company or its executive ...

Guru Focus - 4 days ago

FDA adds two more toxic products to supplement recall: Here’s what you need to...

FDA adds two more toxic products to supplement recall: Here’s what you need to...

Two more products have been added to a safety alert issued by the Food and Drug Administration (FDA)...

The Patriot-News - 2 days ago